Cargando…
Degranulation of Mast Cells as a Target for Drug Development
Mast cells act as key effector cells of inflammatory responses through degranulation. Mast cell degranulation is induced by the activation of cell surface receptors, such as FcεRI, MRGPRX2/B2, and P2RX7. Each receptor, except FcεRI, varies in its expression pattern depending on the tissue, which con...
Autores principales: | Yang, Bo-Gie, Kim, A-Ram, Lee, Dajeong, An, Seong Beom, Shim, Yaein Amy, Jang, Myoung Ho |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10253146/ https://www.ncbi.nlm.nih.gov/pubmed/37296626 http://dx.doi.org/10.3390/cells12111506 |
Ejemplares similares
-
SNARE complex-mediated degranulation in mast cells
por: Woska, Joseph R, et al.
Publicado: (2012) -
Purinergic Signaling in Mast Cell Degranulation and Asthma
por: Gao, Zhan-Guo, et al.
Publicado: (2017) -
NAD(+)-boosting molecules suppress mast cell degranulation and anaphylactic responses in mice
por: Kim, Hyun-Woo, et al.
Publicado: (2022) -
Presence of Mast Cells and Mast Cell Degranulation in Scalp Biopsies of Telogen Effluvium
por: Grace, Shane A, et al.
Publicado: (2017) -
Anaphylactic Degranulation of Mast Cells: Focus on Compound Exocytosis
por: Klein, Ofir, et al.
Publicado: (2019)